Denosumab versus zoledronic acid for primary osteoporosis: a 36-month retrospective cohort study on bone mineral density changes. [PDF]
Zou X +5 more
europepmc +1 more source
Primary denosumab therapy for a three-column pediatric cervical aneurysmal bone cyst: illustrative case. [PDF]
Amin M +5 more
europepmc +1 more source
Mechanisms and management strategies for exacerbated bone loss following denosumab discontinuation. [PDF]
Yang J, Yang M, Zeng Y.
europepmc +1 more source
Giant Cell Tumor of the Distal Humerus: A Rare Location With a Good Response to Denosumab. [PDF]
Mohamed El Kerim M +6 more
europepmc +1 more source
Extensive Giant Cell Tumor Involving Entire Tibia with Talar Extension and Pulmonary Metastases: Successful Limb Preservation with Denosumab and Angioembolization. [PDF]
Kumar P, Tandon N, Nishith N, Gulia A.
europepmc +1 more source
Repurposing Denosumab for Knee Osteoarthritis: A Real-World Signal That Now Needs a Trial. [PDF]
Wei JC, Sun JS, Liu KL, Huang SW.
europepmc +1 more source
Bone health in advanced prostate cancer: pathophysiology and management strategies. [PDF]
McKay RR +4 more
europepmc +1 more source
Longitudinal osteoporosis therapy: treat-to-target and sequential strategies-a narrative review. [PDF]
Tskhakaia I, Danila MI.
europepmc +1 more source
From Risk to Treatment: Clinical Updates in Osteoporosis Management. [PDF]
Alchi K, Chan A.
europepmc +1 more source
Three-year longitudinal assessment of denosumab's efficacy and safety in postmenopausal osteoporosis: a 36-month real-world cohort study. [PDF]
Xia RL, Li C, Wang L, Chao AJ, Wei W.
europepmc +1 more source

